
News|Articles|August 21, 2015
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types
Author(s)Suresh S. Ramalingam
Key Takeaways
- Immunotherapy offers significant advantages over traditional cancer treatments but presents unique toxicity profiles requiring distinct management strategies.
- Immune-related toxicities can affect various organ systems, necessitating vigilant monitoring and intervention by oncologists.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
CAR-T Therapy Helps Manhattan Attorney Achieve Complete Response For NSCLC
2
Breaking Down Metastatic Triple-Negative Breast Cancer Treatments
3
Reflections 10 Years After a Prostate Cancer Diagnosis
4
Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis
5




